Therapy Areas: Central Nervous System
7 June 2019 - - The European Medicines Agency has appointed rapporteurs for the company's marketing authorisation application currently in preparation for narsoplimab for the treatment of hematop...
7 June 2019 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has completed a rolling submission of a New Drug Application to the US Food and Drug Administration...
6 June 2019 - - US-based biopharmaceutical company Puma biotechnology, Inc. (NASDAQ: PBYI) has presented results from the Phase III NALA trial of PB272 (neratinib) in patients with HER2-positive metas...
6 June 2019 - - US-based biopharmaceutical company Celgene Corp. (NASDAQ: CELG) has presented data from the TRANSCEND CLL 004 and TRANSCEND NHL 001 trials studying the investigational anti-CD19 chimer...
4 June 2019 - Kite, a Gilead Company (Nasdaq: GILD), and United States-based Humanigen Inc (HGEN) have established a clinical collaboration to conduct a Phase 1/2 study of lenzilumab, an investigation...
3 June 2019 - - The first patient has been dosed in US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc.'s (NASDAQ: ALNY) Phase 1 study of ALN-AGT, an investigational RNAi therap...
Related Headlines